Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HTR1A | P08908 | 3/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29369095 | 0.85 | LMNA (0.36) | LMNACHRM2TSHRCHRM1ALOX15 | |
| SCHEMBL890933 | 0.85 | LMNA (0.36) | LMNACHRM2TSHRCHRM1ALOX15 | |
| SCHEMBL890869 | 0.82 | KDM4E (0.54) | LMNASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL29367451 | 0.82 | KDM4E (0.54) | LMNASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL8557526 | 0.76 | LMNA (0.62) | LMNACHRM2TSHRCHRM1ALOX15 | |
| SCHEMBL8897368 | 0.76 | LMNA (0.52) | LMNACHRM2TSHRCHRM1ALOX15 | |
| SCHEMBL17911621 | 0.76 | LMNA (0.52) | LMNACHRM2TSHRCHRM1ALOX15 | |
| SCHEMBL10458074 | 0.76 | LMNA (0.52) | LMNACHRM2TSHRCHRM1ALOX15 | |
| SCHEMBL11209770 | 0.76 | ALDH1A1 (0.65) | LMNACHRM2TSHRCHRM1ALOX15 | |
| SCHEMBL15763372 | 0.76 | KDM4E (0.53) | LMNACHRM2TSHRCHRM1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-4679147-A1 | MULTILAYER BODY, OPTICAL ARTICLE, COATING LAYER-CONTAINING MULTILAYER BODY, LENS, EYEGLASSES, AND FILM FOR WINDOWS | TOKUYAMA CORPORATION (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-20250355282-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-11-20 | — | — | US | disclosed |
| US-20250257162-A1 | CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| EP-4582459-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | Kureha Corporation (JP) | 2025-07-09 | — | — | EP | disclosed |
| EP-4582463-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | Kureha Corporation (JP) | 2025-07-09 | — | — | EP | disclosed |
| EP-4560367-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-05-28 | — | — | EP | disclosed |
| CN-119768439-A | Rubber-bonded cellulose fiber, method for producing same, resin composition, method for producing same, and cured resin composition | 株式会社吴羽 | 2025-04-04 | — | — | CN | disclosed |
| CN-119768447-A | Curable composition, cured product, and method for producing cured product | 株式会社吴羽 | 2025-04-04 | — | — | CN | disclosed |
| US-20040141230-A1 | Optical materials having good ultraviolet absorbability and method for producing them | KOSAKA MASAHISA (JP) | 2004-07-22 | — | — | US | disclosed |
| EP-1422197-A1 | DISPERSED INGREDIENT HAVING METAL−OXYGEN | NIPPON SODA CO., LTD. (JP) | 2004-05-26 | — | — | EP | disclosed |
| US-6673888-B2 | PLASTIC LENSES | HOYA CORPORATION (JP) | 2004-01-06 | — | — | US | disclosed |
| US-20020132954-A1 | Optical materials having good ultraviolet absorbability and method for producing them | KOSAKA MASAHISA (JP) | 2002-09-19 | — | — | US | disclosed |
| US-6448304-B1 | POLYURETHANE, POLYTHIOURETHANE OR DIETHYLENE GLYCOL BISALLYLCARBONATE POLYMER; DIPPING IN SOLUTION CONTAINING A DIBENZOYLMETHANE OR A BENZOTRIZOLE COMPOUND; PLASTIC LENS FOR SPECTACLES WHICH ABSORBS ULTRAVIOLET RAYS; LOW YELLOWNESS | HOYA CORPORATION (JP) | 2002-09-10 | — | — | US | disclosed |
| US-6441119-B1 | POLYMERIZING A PLASTIC LENS MONOMER SUCH AS A DIETHYLENE GLYCOL, BISALLYL CARBONATE MIXED WITH THE UV ABSORBENT 2-(2-HYDROXY-4-OCTYLOXYPHENYL)-BENZOTRIAZOLE; NONYELLOWING; EYEGLASSES | HOYA CORPORATION (JP) | 2002-08-27 | — | — | US | disclosed |
| EP-1085349-A2 | Plastic lenses having good ultraviolet absorbability, and method for the production thereof | HOYA CORPORATION (JP) | 2001-03-21 | — | — | EP | disclosed |
| EP-1085348-A2 | Plastic lenses of good ultraviolet absorbability for spectacles and method for producing them | HOYA CORPORATION (JP) | 2001-03-21 | — | — | EP | disclosed |
| US-5955206-A | POLYTHIOETHERS AND ACRYLATE OR VINYL GROUPS FOR CURING TO FORM OPTICAL LENSES | MITSUI CHEMICALS, INC. (JP) | 1999-09-21 | — | — | US | disclosed |
| EP-0742244-A2 | Durable polysulfide composition for optical material | MITSUI TOATSU CHEMICALS, INC. (JP) | 1996-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | CROCC, WASF2, DCXR | LMNA 1472/4885CHRM2 3629/4885TSHR 4622/4885 |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | EHMT1, EHMT2, ASH2L | LMNA 2126/4885CHRM2 1152/4885TSHR 2894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.